Collectively, these interesting observations support a model in which semaphorin-mediated repellent interactions between Neuropilin2-expressing vMNs and Sema6a-positive BC cells constrain vMN cell bodies to the CNS, by opposing the forces exerted by exiting vMN axons on their cell bodies (Table 1). This evidence concerns the gene SEMA6A and breast cancer.